JP2024502471A5 - - Google Patents
Info
- Publication number
- JP2024502471A5 JP2024502471A5 JP2023541519A JP2023541519A JP2024502471A5 JP 2024502471 A5 JP2024502471 A5 JP 2024502471A5 JP 2023541519 A JP2023541519 A JP 2023541519A JP 2023541519 A JP2023541519 A JP 2023541519A JP 2024502471 A5 JP2024502471 A5 JP 2024502471A5
- Authority
- JP
- Japan
- Prior art keywords
- dose
- pharmaceutical composition
- antagonist
- composition according
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163135238P | 2021-01-08 | 2021-01-08 | |
| US63/135,238 | 2021-01-08 | ||
| EP21315241 | 2021-11-10 | ||
| EP21315241.6 | 2021-11-10 | ||
| PCT/US2022/011643 WO2022150605A1 (en) | 2021-01-08 | 2022-01-07 | Methods for treating peanut allergy and enhancing peanut allergen-specific immunotherapy by administering an il-4r antagonist |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024502471A JP2024502471A (ja) | 2024-01-19 |
| JP2024502471A5 true JP2024502471A5 (https=) | 2025-01-15 |
Family
ID=80034850
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023541519A Pending JP2024502471A (ja) | 2021-01-08 | 2022-01-07 | ピーナッツアレルギーを治療するための方法およびｉｌ－４ｒアンタゴニストを投与することによってピーナッツアレルゲン特異的免疫療法を増強する方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220220211A1 (https=) |
| EP (1) | EP4274609A1 (https=) |
| JP (1) | JP2024502471A (https=) |
| KR (1) | KR20230130681A (https=) |
| AU (1) | AU2022206434A1 (https=) |
| CA (1) | CA3204515A1 (https=) |
| IL (1) | IL304240A (https=) |
| MX (1) | MX2023007945A (https=) |
| WO (1) | WO2022150605A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7608693B2 (en) | 2006-10-02 | 2009-10-27 | Regeneron Pharmaceuticals, Inc. | High affinity human antibodies to human IL-4 receptor |
| PT3889181T (pt) | 2012-09-07 | 2024-05-29 | Regeneron Pharma | Um anticorpo antagonista de il-4r para utilização no tratamento da dermatite atópica por administração |
| TWI682781B (zh) | 2013-07-11 | 2020-01-21 | 美商再生元醫藥公司 | 藉由投與ｉｌ－４ｒ抑制劑治療嗜酸性食道炎的方法 |
| WO2015130975A1 (en) | 2014-02-28 | 2015-09-03 | Regeneron Pharmaceuticals, Inc. | Methods for treating skin infection by administering an il-4r antagonist |
| HUE067888T2 (hu) | 2016-09-01 | 2024-11-28 | Regeneron Pharma | Módszerek az allergia megelõzésére vagy kezelésére egy IL-4R antagonista adagolásával |
| CA3132587A1 (en) | 2019-03-21 | 2020-09-24 | Regeneron Pharmaceuticals, Inc. | Combination of il-4/il-13 pathway inhibitors and plasma cell ablation for treating allergy |
| WO2021026205A1 (en) | 2019-08-05 | 2021-02-11 | Regeneron Pharmaceuticals, Inc. | Methods for treating atopic dermatitis by administering an il-4r antagonist |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2990420T3 (en) | 2000-05-26 | 2017-04-03 | Immunex Corp | USE OF INTERLEUKIN-4 RECEPTOR ANTIBODIES AND COMPOSITIONS THEREOF |
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| BRPI0416603A (pt) | 2003-11-07 | 2007-01-30 | Immunex Corp | anticorpo que se liga ao receptor interleucina-4 (il-4) humano |
| MY149079A (en) | 2006-10-02 | 2013-07-15 | Regeneron Pharma | High affinity human antibodies to human il-4 receptor |
| US7608693B2 (en) | 2006-10-02 | 2009-10-27 | Regeneron Pharmaceuticals, Inc. | High affinity human antibodies to human IL-4 receptor |
| US8092804B2 (en) | 2007-12-21 | 2012-01-10 | Medimmune Limited | Binding members for interleukin-4 receptor alpha (IL-4Rα)-173 |
| NZ609557A (en) | 2010-10-06 | 2014-12-24 | Regeneron Pharma | Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies |
| WO2014159609A1 (en) | 2013-03-14 | 2014-10-02 | Allergen Research Corporation | Peanut formulations and uses thereof |
| CN109125283A (zh) | 2013-03-14 | 2019-01-04 | 艾慕恩治疗公司 | 用于口服脱敏的花生制剂的制备 |
| TWI633891B (zh) * | 2013-06-04 | 2018-09-01 | 再生元醫藥公司 | 藉由投與ｉｌ－４ｒ抑制劑以治療過敏及增強過敏原－特異之免疫療法的方法 |
| CN113372446A (zh) | 2016-06-08 | 2021-09-10 | 苏州康乃德生物医药有限公司 | 用于结合白细胞介素4受体的抗体 |
| HUE067888T2 (hu) * | 2016-09-01 | 2024-11-28 | Regeneron Pharma | Módszerek az allergia megelõzésére vagy kezelésére egy IL-4R antagonista adagolásával |
| JPWO2019240288A1 (ja) * | 2018-06-14 | 2021-07-26 | 味の素株式会社 | 抗体に対する親和性物質、および生体直交性官能基を有する化合物またはその塩 |
| KR102330596B1 (ko) | 2018-11-09 | 2021-11-26 | 아주대학교산학협력단 | 인간 il-4 수용체 알파에 대한 고친화도 인간 항체 및 이의 용도 |
| CA3132587A1 (en) * | 2019-03-21 | 2020-09-24 | Regeneron Pharmaceuticals, Inc. | Combination of il-4/il-13 pathway inhibitors and plasma cell ablation for treating allergy |
| US11504426B2 (en) * | 2019-08-05 | 2022-11-22 | Regeneron Pharmaceuticals, Inc. | Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R antagonist |
-
2022
- 2022-01-07 EP EP22700862.0A patent/EP4274609A1/en active Pending
- 2022-01-07 MX MX2023007945A patent/MX2023007945A/es unknown
- 2022-01-07 KR KR1020237026703A patent/KR20230130681A/ko active Pending
- 2022-01-07 CA CA3204515A patent/CA3204515A1/en active Pending
- 2022-01-07 JP JP2023541519A patent/JP2024502471A/ja active Pending
- 2022-01-07 AU AU2022206434A patent/AU2022206434A1/en active Pending
- 2022-01-07 US US17/570,547 patent/US20220220211A1/en active Pending
- 2022-01-07 WO PCT/US2022/011643 patent/WO2022150605A1/en not_active Ceased
-
2023
- 2023-07-04 IL IL304240A patent/IL304240A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024502471A5 (https=) | ||
| JP2022543815A5 (https=) | ||
| JP2022543612A5 (https=) | ||
| TWI633891B (zh) | 藉由投與ｉｌ－４ｒ抑制劑以治療過敏及增強過敏原－特異之免疫療法的方法 | |
| JP2025172841A5 (https=) | ||
| JP2022526738A5 (https=) | ||
| JP2021112207A5 (https=) | ||
| US20220220211A1 (en) | Methods for treating peanut allergy and enhancing peanut allergen-specific immunotherapy by administering an il-4r antagonist | |
| JP2020523004A5 (https=) | ||
| CN114173819A (zh) | 通过施用il-4r拮抗剂治疗过敏和增强过敏原特异性免疫疗法的方法 | |
| US20210148929A1 (en) | Diagnostic tests and methods for assessing safety, efficacy or outcome of allergen-specific immunotherapy (sit) | |
| RU2016136364A (ru) | Способы лечения или предупреждения астмы посредством введения антагониста il-4r | |
| JP2020100653A (ja) | ベンラリツマブによる喘息症状の改善方法 | |
| JP2024544380A (ja) | 抗ＩｇＥ抗体を使用したアレルギー反応の治療 | |
| JP2024532263A5 (https=) | ||
| JP2025501239A5 (https=) | ||
| AU2021293980B2 (en) | Treatment of food allergy using anti-IgE antibodies | |
| RU2022105373A (ru) | Способы лечения аллергии и усиления аллерген-специфической иммунотерапии путем введения антагониста il-4r | |
| CN116887858A (zh) | 通过施用il-4r拮抗剂治疗花生过敏并增强花生过敏原特异性免疫疗法的方法 | |
| NZ783048B2 (en) | Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an il-4r antagonist | |
| HK40016853A (en) | Diagnostic tests and methods for assessing safety, efficacy or outcome of allergen-specific immunotherapy (sit) | |
| HK40016853B (en) | Diagnostic tests and methods for assessing safety, efficacy or outcome of allergen-specific immunotherapy (sit) | |
| WO2026096637A1 (en) | Glp-1 agonists and foralumab combination therapies | |
| RU2023101304A (ru) | Способы лечения аллергии и повышения эффективности аллергенспецифической иммунотерапии путем введения ингибитора ил-4р | |
| RU2022105374A (ru) | Способы лечения атопического дерматита посредством введения антагониста il-4r |